Summary
Definition
History and exam
Key diagnostic factors
- hallucinations
- delusions
- passivity phenomena
- negative symptoms
- disorganised thinking (formal thought disorder)
- catatonia
Other diagnostic factors
- agitation or distress
- suicidal thoughts
- altered cognition
- loss of insight
Risk factors
- family history of schizophrenia
- increasing paternal age
- obstetric complications
- cannabis use
- low IQ
- motor dysfunction
- psychological stress
- childhood adversity
- migrant status
Diagnostic investigations
Treatment algorithm
Contributors
Expert advisers
Stephen Lawrie, MB ChB, MRCPsych, MPhil, MD (Hons), FRCPsych, Hon.FRCP(Edin), FRSE
Professor of Psychiatry and Neuroimaging
University of Edinburgh
Honorary Consultant Psychiatrist
NHS Lothian
Royal Edinburgh Hospital
Edinburgh
UK
Disclosures
SL declares that he has no competing interests.
Acknowledgements
BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:
Fiona Gaughran, MB BCh, BAO (Hons), MRCPI, MD NUI, FRCP, FRCPI, FRCP Edin, FRCPsych, FHEA
Lead Consultant Psychiatrist
National Psychosis Service
Director of Research and Development
South London and Maudsley NHS Foundation Trust
Reader in Psychopharmacology and Physical Health
Institute of Psychiatry, Psychology and Neuroscience
Kings College London
UK
Toby Pillinger, MA(Oxon), BM, BCh, MRCP, PhD
Academic Clinical Lecturer
Institute of Psychiatry, Psychology and Neuroscience
King's College London
UK
Adrian Preda, MD
Professor of Clinical Psychiatry
Department of Psychiatry and Human Behavior
University of California, Irvine School of Medicine
Irvine
CA
Robert G. Bota, MD
Health Sciences Clinical Professor of Psychiatry
University of California
Irvine
CA
Disclosures
FG has received support or honoraria for CME, advisory work, and lectures from Lundbeck, Otsuka, and Sunovion; collaborated with a research group supported by NHS Innovations and Janssen; has a family member with professional links to Lilly and GSK, including shares; and is in part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London and the South London Collaboration for Leadership in Applied Health Research & Care Funding scheme, and by the Maudsley Charity and the Stanley Medical Research Institute. TP has received honoraria for contributing to speaker meetings organised by Sunovion, Lundbeck, and Otsuka. AP declares that he has no competing interests. RGB declares that he has no competing interests.
Peer reviewers
Jonathan Mitchell, MBChB, MRCPsych
Consultant Psychiatrist
Sheffield Health and Social Care NHS Foundation Trust
Sheffield
UK
Disclosures
JM has been involved in production of National Institute for Health and Care Excellence (NICE) guidance on this topic and is a member of the expert advisors panel for the NICE centre for guidelines. He was involved in an NIHR-funded research project on the physical health of people with schizophrenia.
Use of this content is subject to our disclaimer